FDA Approved: ENTECAVIR — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved NorthStar RxLLC's supplemental application for Entecavir (generic entecavir) under ANDA 206872.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

SUPPL AP for ENTECAVIR (ENTECAVIR)